** Shares of immunodiagnostics developer Oncimmune Holdings
Plc ONCON.L rise 7.1% to 52p
** ONCON signs new ImmunoINSIGHTS contracts
** Co says it has signed master services agreement with a
"top 10 pharmaceutical group" for provision of ImmunoINSIGHTS
clinical laboratory services
** Adds it also has new contracts with a UK-based biotech
company and a US research institution
** The contracts give ONCON "continued confidence in outlook
for the business", says co
** Oncimmune touches highest level since Nov. 2, headed for
best day since Sept. 26
(Reporting by Muhammed Husain in Bengaluru)
((Muhammed.Husain@thomsonreuters.com;))